Comprehensive Safety Assessment of Factor VIIA-CTP, A Novel Long Acting FVIIA, Supporting the on-Going Clinical Program
Publication
, Conference
Binder, L; Bar-Ilan, A; Hoffman, M; Hart, G
Published in: HAEMOPHILIA
2016
Duke Scholars
Published In
HAEMOPHILIA
EISSN
1365-2516
ISSN
1351-8216
Publication Date
2016
Volume
22
Start / End Page
97 / 97
Related Subject Headings
- Cardiovascular System & Hematology
- 3202 Clinical sciences
- 1103 Clinical Sciences
Citation
APA
Chicago
ICMJE
MLA
NLM
Binder, L., Bar-Ilan, A., Hoffman, M., & Hart, G. (2016). Comprehensive Safety Assessment of Factor VIIA-CTP, A Novel Long Acting FVIIA, Supporting the on-Going Clinical Program. In HAEMOPHILIA (Vol. 22, pp. 97–97).
Binder, L., A. Bar-Ilan, M. Hoffman, and G. Hart. “Comprehensive Safety Assessment of Factor VIIA-CTP, A Novel Long Acting FVIIA, Supporting the on-Going Clinical Program.” In HAEMOPHILIA, 22:97–97, 2016.
Binder L, Bar-Ilan A, Hoffman M, Hart G. Comprehensive Safety Assessment of Factor VIIA-CTP, A Novel Long Acting FVIIA, Supporting the on-Going Clinical Program. In: HAEMOPHILIA. 2016. p. 97–97.
Binder, L., et al. “Comprehensive Safety Assessment of Factor VIIA-CTP, A Novel Long Acting FVIIA, Supporting the on-Going Clinical Program.” HAEMOPHILIA, vol. 22, 2016, pp. 97–97.
Binder L, Bar-Ilan A, Hoffman M, Hart G. Comprehensive Safety Assessment of Factor VIIA-CTP, A Novel Long Acting FVIIA, Supporting the on-Going Clinical Program. HAEMOPHILIA. 2016. p. 97–97.
Published In
HAEMOPHILIA
EISSN
1365-2516
ISSN
1351-8216
Publication Date
2016
Volume
22
Start / End Page
97 / 97
Related Subject Headings
- Cardiovascular System & Hematology
- 3202 Clinical sciences
- 1103 Clinical Sciences